The widespread chronic pain experienced by FM patients may be linked to serotonin's role in muscle function and skeletal muscle fiber growth (Chandran et al., 2012)
According to Ipsen, NAPOLI 3 is the first positive Phase III trial in mPDAC to show better OS compared to the current standard-of-care regimen, which consists of nab-paclitaxel and gemcitabine
others find it initially disruptive
This product is supplied exclusively for laboratory and scientific research applications
Working with Canadian-based suppliers offers advantages including faster shipping, CAD pricing, and customer service familiar with Canadian needs
Shepherd J, Barter P, Carmena R, et al